Edition:
India

Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

81.59USD
1:30am IST
Change (% chg)

$0.63 (+0.78%)
Prev Close
$80.96
Open
$81.36
Day's High
$81.78
Day's Low
$80.89
Volume
2,367,546
Avg. Vol
3,366,739
52-wk High
$87.07
52-wk Low
$62.09

About

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes... (more)

Overall

Beta: 0.83
Market Cap(Mil.): $176,050.70
Shares Outstanding(Mil.): 2,727.35
Dividend: 0.47
Yield (%): 2.91

Financials

  MRK.N Industry Sector
P/E (TTM): 35.16 29.88 32.67
EPS (TTM): 1.84 -- --
ROI: 6.58 14.90 14.49
ROE: 12.28 16.02 15.79

U.S. judge strikes down Trump administration rule requiring drug prices in TV ads

A federal judge on Monday dealt a blow to the Trump administration by striking down a new rule that would have forced pharmaceutical companies to include the wholesale prices of their drugs in television advertising.

09 Jul 2019

Merck CEO sees legal challenge if U.S. adopts drug pricing based on other countries

NEW YORK Merck & Co Chief Executive Ken Frazier said on Thursday a rule to base the price the U.S. government pays for some prescription drugs in it Medicare program on lower prices in other countries would face legal challenges if adopted.

21 Jun 2019

Merck CEO sees legal challenge if U.S. adopts drug pricing based on other countries

NEW YORK, June 20 Merck & Co Chief Executive Ken Frazier said on Thursday a rule to base the price the U.S. government pays for some prescription drugs in it Medicare program on lower prices in other countries would face legal challenges if adopted.

21 Jun 2019

Walmart, Merck in blockchain collaboration with FDA

June 13 IBM Corp, Merck & Co, KPMG and Walmart Inc said on Thursday they will be a part of U.S. Food and Drug Administration's pilot program that will explore using blockchain to identify, track and trace prescription drugs.

13 Jun 2019

Merck's Keytruda wins FDA approval to treat head and neck cancer

Merck & Co Inc said on Tuesday its blockbuster cancer drug Keytruda won approval from the U.S. Food and Drug Administration to treat a type of head and neck cancer.

11 Jun 2019

UPDATE 1-Merck's Keytruda wins FDA approval to treat head and neck cancer

June 11 Merck & Co Inc said on Tuesday its blockbuster cancer drug Keytruda won approval from the U.S. Food and Drug Administration to treat a type of head and neck cancer.

11 Jun 2019

Merck's Keytruda wins FDA approval to treat head and neck cancer

June 11 Merck & Co Inc said on Tuesday its blockbuster cancer drug Keytruda won approval from the U.S. Food and Drug Administration to treat a type of head and neck cancer.

11 Jun 2019

Merck to buy Tilos Therapeutics for up to $773 million

Drugmaker Merck & Co Inc said on Monday it agreed to buy privately held Tilos Therapeutics for up to $773 million, bolstering its pipeline of drugs to treat cancer and autoimmune diseases.

10 Jun 2019

Merck to buy Tilos Therapeutics for up to $773 mln

June 10 Drugmaker Merck & Co Inc said on Monday it agreed to buy privately held Tilos Therapeutics for up to $773 million, bolstering its pipeline of drugs to treat cancer and autoimmune diseases.

10 Jun 2019

US STOCKS-Nasdaq confirms correction as Facebook, Alphabet, Amazon drag

* Facebook, Amazon, Alphabet tumble on fears of regulatory risks

04 Jun 2019

Earnings vs. Estimates